https://www.thebodypro.com/category/first-line-hiv-treatment
HIV Treatment Strategies

First-Line HIV Treatment

The Latest

Weight Gain and HIV Antiretrovirals photo illustration
Features

Weight Gain and HIV Antiretrovirals: Lipodystrophy for the Integrase Era

In a busy year buzzing with the flight of potentially revolutionary new HIV medications, evidence of large weight increases accompanying dolutegravir and bictegravir has been a bombshell.

Two-Drug TANGO photo illo
Features

TANGO, the Most Relevant Two-Drug Antiretroviral Therapy Trial of the Year

Whether lamivudine/dolutegravir is sufficient to achieve and maintain viral suppression was last year's question. As we move to 2020, a new question could be asked: Are three-drug regimens still necessary?

human skeleton posed in thinking position
News

This Week in HIV Research: If I Could Turn Back Ossein

Nov. 7, 2019: Zoledronic acid to prevent bone loss; bone benefits for older patients switching from TDF to TAF; periperhal artery disease among women; motor dysfunction and cognitive impairment.

pill bottles on page full of data
Conference Coverage

Two-Drug HIV Regimen Works Well Except in People With Low CD4 Count, Study Finds

The combination of dolutegravir and lamivudine is effective for treatment-naive patients regardless of age, gender, or race, according to a new subgroup analysis of the GEMINI clinical studies.

couple on the boardwalk surrounded by seagulls
News

This Week in HIV Research: When STIs Flock Together

July 18, 2019: Anal neoplasia risk amidst comorbid HPV and chlamydia; predictive modeling for PrEP outreach; long-term benefits of hepatitis C cure in coinfection; first-line therapy with dolutegravir/lamivudine.

Woman's hands taking pills
News

After Pilot, Whitman-Walker Health Establishes Same-Day HIV Treatment Start Program

"We're very much putting the patient in the driver's seat," said Heather Alt, deputy director of nursing with Whitman-Walker. "If folks didn't feel ready, we would not push them to start."

Magnifying glass on antique anatomy book: Heart image
News

This Week in HIV Research: Matters of the Heart

May 30, 2019: Myocardial infarction risk among people with HIV; dolutegravir vs. efavirenz; a new way to estimate date of seroconversion; identifying people at imminent risk for disengagement from care.

person holds sheet of paper with question mark on it as another person shrugs in background
News

This Week in HIV Research: Unexpected Outcomes

May 2, 2019: patient-centered care model improves viral suppression; subpar immune responses when baseline CD4 tops 500; when CD4 plummets despite viral suppression; vaccination, immunoglobulin, and hepatitis A exposure.

CDC: Most HIV Transmissions Are From People Who Are Not in Care Img
Men Who Have Sex With Men

CDC: Most HIV Transmissions Are From People Who Are Not in Care

More than 80 percent of U.S. HIV transmissions in 2016 were from people who were unaware of their status or had been diagnosed but lost to follow-up.

Promo Image
News

This Week in HIV Research: Prevention and Treatment in the Real World

Impact of intimate partner violence on PrEP attitudes among women; evolution of first-line HIV treatment failure rates; cumulative low-level viremia and virologic failure risk; HIV drug levels in breast milk versus plasma.